Showing results (1451-1460 of 1,618) with videos related to

Sort By:
Pageof 162
Molecular Ecology|June 30, 2021
Prevalence and polymorphism of a mussel transmissible cancer in EuropeMaurine Hammel, Alexis Simon, Christine Arbiol, et al.
Ebiomedicine|April 2, 2024
Using generative AI to investigate medical imagery models and datasetsOran Lang, Doron Yaya-Stupp, Ilana Traynis, et al.
Nature Communications|June 3, 2026
Diversity-driven biochemical survey reveals widespread dimerization throughout the rubisco superfamilyAlexander J Kehl, Leah Taylor-Kearney, Alexander L Jaffe, et al.
Annals of Surgical Oncology|June 29, 2026
Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives PrognosisEdoardo Maria Muttillo, Daniel Cherqui, Marc-Anthony Chouillard, et al.
The Lancet. Gastroenterology & Hepatology|April 12, 2017
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trialJean-Baptiste Bachet, Pascal Hammel, Jérôme Desramé, et al.
Cancers|September 10, 2021
Targeting DNA Damage Repair Mechanisms in Pancreas CancerLukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, et al.
Clinical Genetics|August 22, 2019
Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohortMathias Schwartz, Clement Korenbaum, Meriem Benfoda, et al.
Cancer Medicine|July 18, 2019
Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trialEmilie Charton, Jean-Baptiste Bachet, Pascal Hammel, et al.
Elife|August 10, 2019
Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12aGavin J Knott, Brady F Cress, Jun-Jie Liu, et al.
Physical Review Letters|August 25, 2004
Measurement of the absolute hohlraum-wall albedo under ignition foot drive conditionsO S Jones, S H Glenzer, L J Suter, et al.
Pageof 162